PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 2, 2026Scientific Reports0 citationsOpen Access

Epidemiology and prevention of HPV-driven cervical cancer in urban–rural China: a population-based study of 60,280 women

View Full Paper
LZLizhen ZengZCZhanfei ChenKWKangying Wang

Key Points

  • This research aims to investigate HPV infection rates and evaluate cervical cancer prevention strategies among women in urban and rural China.
  • Cross-sectional analysis of screening results from 60,280 women aged 35-64
  • Utilized HPV genotyping for 14 high-risk subtypes
  • Employed liquid-based cytology (TCT) and histopathological examination
  • Assessed infection prevalence, subtype distribution, and screening effectiveness
  • Overall HPV infection prevalence was 9.27%
  • HPV 52, HPV 58, and HPV 16 were the most prevalent genotypes
  • Cervical cancer incidence peaked at 95 cases per 100,000 in women aged 55-59
  • Only 1.33% of women engaged in self-screening initiatives
  • Urban-rural disparities in HPV prevalence and low screening rates were observed

Abstract

Cervical cancer continues to pose a significant public health burden in China, where marked differences persist in HPV infection rates and screening participation between urban and rural populations. We investigated HPV epidemiology and evaluated prevention approaches in Putian, a southeastern Chinese region representative of broader demographic patterns. This cross-sectional study analyzed screening results from 60,280 women aged 35-64 years who participated in Putian's free cervical cancer screening program between 2021 and 2023. We employed HPV genotyping (14 high-risk subtypes), liquid-based cytology (TCT), and histopathological examination to assess infection rates, subtype distribution, and screening effectiveness. The data provided insights into both epidemiological patterns and diagnostic performance within this population. The overall human papillomavirus (HPV) infection prevalence was 9.27% (95% CI: 9.04-9.50), with HPV 52 (35.61%), HPV 58 (16.56%), and HPV 16 (12.38%) emerging as the most prevalent genotypes. Cervical cancer incidence peaked in women aged 55-59 (95 cases per 100,000), with a secondary peak observed in the 50-54 age group (89 cases per 100,000). In addition, a concerning early-onset pattern appeared in the 40-44 age group (46 cases per 100,000). The national incidence rate averaged 56 cases per 100,000. HPV 16/18 infections accounted for the majority of cervical cancer cases, with HPV 58/33/52 representing secondary high-risk genotypes. ThinPrep cytologic test (TCT) screenings revealed clinically significant underdiagnosis and overdiagnosis rates. Only 1.33% of women participated in self-screening initiatives. Urban-rural disparities in HPV 52/58/33 prevalence persist alongside low screening rates, underscoring the urgency of implementing targeted vaccination strategies, particularly the 9-valent HPV vaccine, and adopting advanced triage methods such as methylation testing in Putian.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Zeng et al. (2026) studied this question.

synapsesocial.com/papers/6980fc37c1c9540dea80df3bhttps://doi.org/10.1038/s41598-025-34014-2
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Human papillomavirus genotyping for predicting disease progression in women with biopsy-negative or cervical intraepithelial neoplasia grade 1 of low-grade intraepithelial lesion cytology2023 · 5 citations
  2. 2Results of cytology and high-risk human papillomavirus testing in females with cervical adenocarcinoma in situ2013 · 26 citations
  3. 3Genotype distribution characteristics of multiple human papillomavirus in women from the Taihu River Basin, on the coast of eastern China2017 · 17 citations
  4. 4Cervical Human Papillomavirus Infection (HPV) and High Oncogenic Risk Genotypes among Women Living with HIV in Asia: A Meta-Analysis2021 · 21 citations
  5. 5Natural history of histologically moderate cervical dysplasia in adolescent and young women2014 · 11 citations